As reported by IPWatchdog, Moderna is facing lawsuits in the United States from biotech firms, Arbutus Biopharma Corporation and Genevant Sciences GmbH.
Both companies allege that Moderna has infringed six of their U.S. patents relating to lipid nanoparticle (“LNP”) delivery technology. LNP delivery systems are crucial for mRNA therapies like Moderna’s COVID-19 vaccine by allowing treatments to bypass the human immune system without being destroyed.
Moderna has reportedly denied all allegations and vowed to vigorously defend itself against the claims made against it in court.
The plaintiffs in this action are seeking compensation, rather than an injunction, which is typically sought in such actions. If infringement is found, compensation through damages would likely be assessed through a “reasonable royalty”.
As reported by the Associated Press, Columbia Sportswear has sued Columbia University, claiming that the university infringed the sportswear company’s trademark and breached an agreement between the…
Verizon and Headwater Research LLC have reportedly agreed to settle a patent infringement lawsuit that ended with a $175 million USD jury verdict against the telecom giant. Headwater, a…
In a recent copyright infringement case, the Jiangsu High Court ruled in favor of Nintendo, awarding the company approximately $28,000 USD, or 200,000 RMB, and an injunction against an unnamed…
Recent tariff measures affecting pharmaceutical products and ingredients have introduced new compliance and cost considerations for manufacturers, distributors, and importers operating in Canada and…
As reported by Reuters, the 9th U.S. Circuit Court of Appeals has ruled that Roger Hodgson, the former Supertramp singer and songwriter, must compensate three former band members for a share of…
As reported by Reuters, three former employees of Taiwan Semiconductor Manufacturing Company ("TSMC") were charged with violating security law and other offences in Taiwan. The prosecutors have…
